ELVN stock

Enliven Therapeutics Inc. (ELVN) financials · $2.11B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Enliven Therapeutics Inc. (ELVN) $2.11B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$119.7M-$104.6M
Net Income-$103.7M-$89.0M
EPS (Diluted)-$1.83-$1.89
Cached annual balance sheet
LineFY2025FY2024
Total Assets$476.2M$325.8M
Current Assets$474.9M$318.1M
Cash & Equivalents$98.9M$124.1M
PP&E$34.0K$458.0K
Total Liabilities$16.6M$15.9M
Current Liabilities$16.6M$15.9M
Shareholders' Equity$459.6M$309.8M
Retained Earnings-$347.2M-$243.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$70.3M-$73.2M
CapEx$158.0K$44.0K
Investing Cash Flow-$173.8M-$36.0M
Financing Cash Flow$218.9M$133.2M
Free Cash Flow-$70.5M-$73.2M
These statements as JSON? API free 100/day

FAQ

What is ELVN P/E and revenue?

Enliven Therapeutics Inc. (ELVN) $2.11B cap.

What is ELVN revenue?

ELVN income-statement cache has no revenue figure yet.

Is ELVN profitable?

Enliven Therapeutics Inc. last cached net income is -$103.7M (FY2025).

What are ELVN total assets?

Enliven Therapeutics Inc. last cached total assets are $476.2M (FY2025).

What is ELVN free cash flow?

Enliven Therapeutics Inc. last cached free cash flow is -$70.5M (FY2025).

Not investment advice. Cached statements, not a live tape.